Translational Research
Volume 156, Issue 2 , Pages 91-97 , August 2010

Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma

  • Helen Dimaras

      Affiliations

    • Divisions of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Diane Rushlow

      Affiliations

    • Department of Retinoblastoma Solutions, University Health Network, University of Toronto, Ontario, Canada
    • ,
  • William Halliday

      Affiliations

    • Department of Pathology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • ,
  • John J. Doyle

      Affiliations

    • Divisions of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Paul Babyn

      Affiliations

    • Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Esteban M. Abella

      Affiliations

    • Department of Pediatric Hematology-Oncology, Banner Children's Hospital, Mesa, Ariz
    • ,
  • James Williams

      Affiliations

    • Department of Pediatric Hematology-Oncology, Banner Children's Hospital, Mesa, Ariz
    • ,
  • Elise Héon

      Affiliations

    • Department of Ophthalmology/Visual Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Brenda L. Gallie

      Affiliations

    • Department of Retinoblastoma Solutions, University Health Network, University of Toronto, Ontario, Canada
    • Department of Ophthalmology/Visual Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • Department of Applied Molecular Oncology, University Health Network, University of Toronto, Ontario, Canada
    • ,
  • Helen S.L. Chan

      Affiliations

    • Divisions of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Helen Chan, Division of Hematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8

Received 14 January 2010 ,Revised 22 April 2010 ,Accepted 25 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by grants from The Ontario Institute for Cancer Research and from the Canadian Retinoblastoma Society and the Royal Arch Masons of Canada. Funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.

PII: S1931-5244(10)00115-5

doi: 10.1016/j.trsl.2010.05.009

Translational Research
Volume 156, Issue 2 , Pages 91-97 , August 2010

Article Tools

* Image Usage & Resolution